• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Neoadjuvant therapy for localized pancreatic cancer: support is growing?

作者信息

Evans Douglas B, Ritch Paul S, Erickson Beth A

机构信息

From the Pancreatic Cancer Program, Departments of Surgery, Medicine, and Radiation Oncology, Medical College of Wisconsin, Milwaukee, WI.

出版信息

Ann Surg. 2015 Jan;261(1):18-20. doi: 10.1097/SLA.0000000000000996.

DOI:10.1097/SLA.0000000000000996
PMID:25599323
Abstract
摘要

相似文献

1
Neoadjuvant therapy for localized pancreatic cancer: support is growing?局部胰腺癌的新辅助治疗：支持率在上升吗？
Ann Surg. 2015 Jan;261(1):18-20. doi: 10.1097/SLA.0000000000000996.
2
[After neoadjuvant therapy of pancreatic cancer the classical radiological criteria for resectability are no longer applicable].胰腺癌新辅助治疗后，经典的可切除性放射学标准不再适用。
Chirurg. 2015 Feb;86(2):183. doi: 10.1007/s00104-015-2987-z.
3
Safety and efficacy of neoadjuvant FOLFIRINOX treatment in a series of patients with borderline resectable pancreatic ductal adenocarcinoma.新辅助FOLFIRINOX方案治疗一系列临界可切除胰腺导管腺癌患者的安全性和有效性
Acta Oncol. 2013 Aug;52(6):1231-3. doi: 10.3109/0284186X.2013.771821. Epub 2013 Feb 27.
4
Unresectable locally advanced pancreatic cancer: treatment with neoadjuvant leucovorin, fluorouracil, irinotecan, and oxaliplatin and assessment of surgical resectability.不可切除的局部晚期胰腺癌：采用新辅助亚叶酸钙、氟尿嘧啶、伊立替康和奥沙利铂治疗及手术可切除性评估
J Clin Oncol. 2013 Jan 20;31(3):e37-9. doi: 10.1200/JCO.2012.44.0339. Epub 2012 Dec 10.
5
Multifocal anaplastic pancreatic carcinoma requiring neoadjuvant chemotherapy and total pancreatectomy: report of a case.需要新辅助化疗和全胰切除术的多灶性间变性胰腺癌：病例报告
JOP. 2013 May 10;14(3):289-91. doi: 10.6092/1590-8577/1416.
6
A Pancreatic Predicament.
Int J Radiat Oncol Biol Phys. 2017 Oct 1;99(2):296-297. doi: 10.1016/j.ijrobp.2017.05.024.
7
Complete radiological response of an initially locally advanced unresectable pancreatic cancer to chemoradiotherapy using FOLFIRINOX regimen: report of a case.一例初始局部进展期不可切除胰腺癌经FOLFIRINOX方案放化疗后达到完全放射学缓解：病例报告
Clin Res Hepatol Gastroenterol. 2015 Apr;39(2):e29-31. doi: 10.1016/j.clinre.2014.08.011. Epub 2014 Oct 3.
8
FOLFIRINOX: a new standard treatment for advanced pancreatic cancer?FOLFIRINOX：晚期胰腺癌的一种新标准治疗方案？
Lancet Oncol. 2011 Jan;12(1):8-9. doi: 10.1016/S1470-2045(10)70237-0. Epub 2010 Nov 1.
9
Three-drug combination regimen in pancreatic cancer treatment: are we there yet?胰腺癌治疗中的三联药物联合方案：我们做到了吗？
JOP. 2011 Mar 9;12(2):78-82.
10
Locally advanced anaplastic pancreatic adenocarcinoma with initial response to FOLFIRINOX and rapid progression after five months.局部晚期间变大细胞胰腺腺癌，初始 FOLFIRINOX 治疗有效，但五个月后迅速进展。
Pancreatology. 2012 Jan-Feb;12(1):35-8. doi: 10.1016/j.pan.2012.01.001. Epub 2012 Jan 3.

引用本文的文献

1
Use of Vascular Shunt at the Time of Pancreatectomy with Venous Resection: A Systematic Review.胰腺切除联合静脉切除时血管分流术的应用：一项系统评价
Cancers (Basel). 2024 Jun 27;16(13):2361. doi: 10.3390/cancers16132361.
2
Neoadjuvant Treatment in Locally Advanced Pancreatic Cancer (LAPC) Patients with FOLFIRINOX or Gemcitabine NabPaclitaxel: A Single-Center Experience and a Literature Review.局部晚期胰腺癌（LAPC）患者使用FOLFIRINOX或吉西他滨纳米白蛋白紫杉醇进行新辅助治疗：单中心经验及文献综述
Cancers (Basel). 2019 Jul 13;11(7):981. doi: 10.3390/cancers11070981.
3
A New Strategy to Control and Eradicate "Undruggable" Oncogenic K-RAS-Driven Pancreatic Cancer: Molecular Insights and Core Principles Learned from Developmental and Evolutionary Biology.
一种控制和根除“不可成药的”致癌性K-RAS驱动的胰腺癌的新策略：从发育生物学和进化生物学中获得的分子见解和核心原理
Cancers (Basel). 2018 May 14;10(5):142. doi: 10.3390/cancers10050142.
4
Decreased Skeletal Muscle Volume Is a Predictive Factor for Poorer Survival in Patients Undergoing Surgical Resection for Pancreatic Ductal Adenocarcinoma.骨骼肌量减少是胰腺导管腺癌患者接受手术切除后生存状况较差的预测因素。
J Gastrointest Surg. 2018 May;22(5):831-839. doi: 10.1007/s11605-018-3695-z. Epub 2018 Feb 1.
5
Meta-analyses of treatment standards for pancreatic cancer.胰腺癌治疗标准的荟萃分析。
Mol Clin Oncol. 2016 Mar;4(3):315-325. doi: 10.3892/mco.2015.716. Epub 2015 Dec 18.
6
Adjuvant and neoadjuvant therapies in resectable pancreatic cancer: a systematic review of randomized controlled trials.可切除胰腺癌的辅助和新辅助治疗：随机对照试验的系统评价
Med Oncol. 2016 Mar;33(3):28. doi: 10.1007/s12032-016-0742-z. Epub 2016 Feb 17.